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“There are the patients we want to see and the patients we
have to see,” my attending cautioned during my medical
internship. When we relate to a patient’s story, enjoy the con-
versation, feel capable or curious, we naturally spend more
time. What happens when we struggle to connect, when a
patient declines treatment, or has many complex issues that we
feel incapable of addressing?What happens when we feel help-
less? As an experienced medical oncologist observed, “There’s a
groan that is uttered when I say the word schizophrenia.”
Dr. van Laarhoven felt exhausted, angry, and powerless as
she cared for Mr. E. Her colleague asked, “Why did you try so
hard for this one patient? Shouldn’t you have accepted that
Mr. E. had a severe comorbidity which precluded curative cancer
treatment?” I also frequently hear, “Shouldn’t we have respected
his decision?”
AUTONOMY OR AVOIDANCE OF RESPONSIBILITY?
It would have been much easier to accept Mr. E’s refusal of
care. Instead, Dr. van Laarhoven made multiple choices to dedi-
cate additional effort. She could have stopped trying when
Mr. E. left the hospital, when the ﬁrst psychiatric evaluation failed
to recognize an urgent need for hospitalization, andwhen the sec-
ond psychiatric evaluation posed another barrier to cancer care.
Respecting Mr. E’s autonomy would require less effort. By
honoring his wishes, we might also stop feeling so ineffective.
We can cite our obligation to do no harm, to avoid giving toxic
chemotherapy if the patient will not be adherent with care. But
accepting Mr. E.’s refusal did not feel good or right to the oncol-
ogy fellow. Focusing solely on Mr. E’s autonomy allows us to
avoid our responsibility as physicians: to ensure his understand-
ing, incorporate psychiatric treatment, and learn about his
goals. If we don’t listen to our gut and choose to try harder, we
communicate that Mr. E’s life matters less.
WITHOUTA DIFFERENTAPPROACH, MANY PATIENTS LIKE
MR. E. WILL NOT RECEIVE EQUITABLE CANCER TREATMENT
Mr. E’s story is not uncommon. Thirteen million people in the
U.S. have serious mental illness, including three million with
schizophrenia [1]. Individuals with schizophrenia are less likely
to receive timely, guideline-concordant cancer care, which con-
tributes to markedly increased cancer mortality and premature
death [2]. People with schizophrenia die nearly 30 years earlier
than the general population and cancer is the second-leading
cause of death [3, 4].
This disparity is unrecognized and overwhelming in scope.
However, with a proactive, integrated approach, we can
improve cancer care delivery for this complex population. We
can unlearn the pattern of helplessness by making small choices
to effectively engage patients in care [5].
I am a psychiatrist and health services researcher, embed-
ded in a cancer center, who specializes in serious mental illness
and cancer. This year, our team has cared for more than 80
patients with serious mental illness and cancer. I continue to be
struck by how frequently patients who initially decline treat-
ment become engaged in care and express their gratitude and
surprise that we cared enough to try.
HOW CANWE INCREASE PATIENT UNDERSTANDING AND
FACILITATE RECEIPT OF CARE?
In Massachusetts, any physician or mental health clinician can
order an involuntary evaluation when concerned about risk of
harm to self or others, or grave inability to care for self. This
step does not mandate hospitalization or treatment, but
instead means that we are worried enough that we need to
assess the patient in person.What are the risks of a mandatory
evaluation in the emergency department? Mr. E. could become
angry at being forced to come to the hospital, which could
impact the patient-clinician alliance. Mr. E. may be at increased
risk for receiving cancer treatment against his wishes. The risk
of not mandating that evaluation is Mr. E.’s preventable death.
As an experienced mental health nurse summarized, “I’m all for
patient rights but someone has to say, ‘You ain’t dying on my
watch.’”
My colleagues in the cancer center and community fre-
quently ask, “What is your threshold for involuntary
treatment?” I start by imagining that Mr. E. is a close friend liv-
ing in another state: overwhelmed, disorganized, and emaci-
ated, with a serious infection that is amenable to treatment. It
is unclear that Mr. E. understands the risk of not having his
infection treated. Despite his desire to stay out of the hospital,
he comes voluntarily to see his radiation oncologist, reﬂecting
some interest in receiving cancer treatment. To meaningfully
consider his autonomy, we need to take three initial steps to (a)
build patient understanding, (b) treat psychiatric symptoms
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that may impact decision-making, and (c) learn about how can-
cer treatment ﬁts with the patient’s values and priorities for his
or her life.
First, we can use our medical knowledge and experience to
educate Mr. E. and any community supports about the risk of
not receiving treatment [6]. Given the symptoms of schizophre-
nia frequently include deﬁcits in memory and attention, chal-
lenges with abstract reasoning, and difﬁculty with trust, we will
likely need to explain that risk in multiple ways and break that
information down into small, digestible pieces. An evaluation
provides opportunity for engagement. Ideally, together with his
trusted radiation oncologist, we would educate Mr. E. about
the risk of not receiving chemotherapy and not treating his
aspiration pneumonia.
Next, we need to treat Mr. E’s psychiatric illness. He was
more disorganized, scared, and delusional, and his fears were
impacting his decision-making, yet he declined psychiatric
treatment. Although people with psychiatric illness frequently
confront additional barriers to cancer care, it can help to
approach treating a psychiatric comorbidity with the same
framework we use to address cardiovascular disease. With
uncontrolled atrial ﬁbrillation, we consult cardiology, control
symptoms, and comanage cancer treatment. Similarly, we need
to consult psychiatry at cancer diagnosis, and psychiatric con-
sultation has to be available, timely, and relevant. Even if Mr. E.
declined psychiatric consultation, a mental health clinician can
support the oncology team. Adjusting psychiatric medications
and establishing trust may decrease the intensity of fear,
improve sleep, and organize thinking.
Most importantly, we can think with the person and any
family or community-based clinicians about how best to sup-
port this person and his values [7]. Mr. E. sought care from the
radiation oncologist. He left the hospital because he was angry
about a lawsuit, not because of a longstanding objection to
chemotherapy. Maybe his cancer care could have been framed
in a way that helped him to meet his goals of maintaining his
independence and thinking clearly. A person-centered approach
might include a joint visit with psychiatry and radiation
oncology.
PROMOTING EQUITY: THE NEED FOR INTEGRATION OF
MENTAL HEALTH AND CANCER CARE
What is our obligation to Mr. E.? We need to consider the sig-
niﬁcant risk of not evaluating and hospitalizing patients, of not
making sure that the individual, and when present, the individ-
ual’s surrogate decision-maker, understands the risk of not
treating the cancer. It will take more time for a patient like Mr.
E. As clinicians, our gut instinct is to dedicate that extra time.
We start the day wanting to give everyone the best possible
care. Yet sometimes our efforts feel futile. In the U.S., as in The
Netherlands, community mental health and cancer care are
delivered in siloed health systems that are not designed to
address Mr. E’s complex needs. The fragmentation of mental
health and cancer care can contribute to misunderstanding,
miscommunication, delays, and disruptions in care. Reimburse-
ment models rarely support engaging patients outside of ofﬁce
visits. Rarely do we have multidisciplinary teams in place to
support each other and the patient when we feel frustrated,
exhausted, and powerless. However, with different approaches,
we can increase access to care and begin to unlearn that sense
of helplessness.
We need to be creative, persistent, and respectful as we try
to understand what matters to patients. With the overall goal
of promoting equity in cancer care, we can help people with
serious mental illness, who have more often been the patients
we ignored, get the best possible cancer care.
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Editor’s Note:
See the related article, “On the Receiving End of Autonomy and Law,” by Hanneke W. M. van Laarhoven et al., on page 1143
of this issue.
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